Abivax
Abivax is a France-based biopharmaceutical company that develops and commercializes drugs for the treatment of inflammatory diseases, viral infections and cancer.
Business Model:
Revenue: $11M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Abivax Information
Geographic Data
Address: 5, rue de la Baume
City: Paris
State: île-de-france
Zip: 75008
Country: FR
Financial Info
Stage:
post ipo equity
Raised Last:
$49M
Raised Total:$104M
Social
Metrics
7,174,086Website Global Rank
894Website Monthly Traffic
Twitter Followers
Description
Abivax is a France-based biopharmaceutical company that develops and commercializes drugs for the treatment of inflammatory diseases, viral infections and cancer.
Contact Phone:
Contact Email:
Abivax went public on 7/3/2015 on the PA
Listed Exchange:
PA
IPO Date:
7/3/2015
Ticker Symbol:
ABVX
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
